Market Research Logo

Zydus Cadila Healthcare Ltd - Product Pipeline Review - 2016

Zydus Cadila Healthcare Ltd - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Zydus Cadila Healthcare Ltd - Product Pipeline Review - 2016’, provides an overview of the Zydus Cadila Healthcare Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Zydus Cadila Healthcare Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Zydus Cadila Healthcare Ltd
  • The report provides overview of Zydus Cadila Healthcare Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Zydus Cadila Healthcare Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Zydus Cadila Healthcare Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Zydus Cadila Healthcare Ltd’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Zydus Cadila Healthcare Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Zydus Cadila Healthcare Ltd’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Introduction
Global Markets Direct Report Coverage
Zydus Cadila Healthcare Ltd Snapshot
Zydus Cadila Healthcare Ltd Overview
Key Facts
Zydus Cadila Healthcare Ltd - Research and Development Overview
Key Therapeutic Areas
Zydus Cadila Healthcare Ltd - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Zydus Cadila Healthcare Ltd - Pipeline Products Glance
Zydus Cadila Healthcare Ltd - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Zydus Cadila Healthcare Ltd - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Zydus Cadila Healthcare Ltd - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Zydus Cadila Healthcare Ltd - Unknown Stage Pipeline Products
Unknown Products/Combination Treatment Modalities
Zydus Cadila Healthcare Ltd - Drug Profiles
(diphtheria + haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + tetanus) (pentavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + Haemophilus influenzae [serotype B] + pertussis (whole-cell) + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + pertussis (whole-cell) + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diphtheria + tetanus) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(measles + mumps + rubella + varicella) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(measles + mumps + rubella) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
bevacizumab biosimilar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biosimilar 1 for Nephrology, Acute Myocardial Infarction and Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biosimilar 2 for Diabetes, Infertility and Rheumatoid Arthritis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biosimilar 3 for Rheumatoid Arthritis, Acute Myocardial Infarction, Oncology and Inflammation - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biosimilar 4 for Acute Myocardial Infarction, Infertility, Oncology and Thrombosis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biosimilar 5 for Infertility and Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biosimilar 6 for Infertility, Oncology and Immunology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biosimilar 7 for Infertility, Immunology and Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Crimean-Congo hemorrhagic fever vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Ebola vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Haemophilus influenzae B vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis A vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis B vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis E vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
human papillomavirus vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (tetravalent, split virion) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
influenza [strains A/H1N1 + A/H3N2 + B/Yamagata] (trivalent, split virion) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
influenza [strains A/H1N1 + A/H3N2 + B/Yamagata] (trivalent, virus like particle) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
interferon beta-1b - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Japanese encephalitis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MAb-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MAb-2 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MAb-3 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MAb-4 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
malaria vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
measles vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PEG-EPO - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Rabimabs - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rituximab biosimilar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
saroglitazar - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tetanus vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
typhoid vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ZYAN-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ZYDPLA-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ZYH-7 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ZYTP-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Zydus Cadila Healthcare Ltd - Pipeline Analysis
Zydus Cadila Healthcare Ltd - Pipeline Products by Target
Zydus Cadila Healthcare Ltd - Pipeline Products by Route of Administration
Zydus Cadila Healthcare Ltd - Pipeline Products by Molecule Type
Zydus Cadila Healthcare Ltd - Pipeline Products by Mechanism of Action
Zydus Cadila Healthcare Ltd - Dormant Projects
Zydus Cadila Healthcare Ltd - Company Statement
Zydus Cadila Healthcare Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Zydus Cadila Healthcare Ltd, Key Facts
Zydus Cadila Healthcare Ltd - Pipeline by Indication, 2016
Zydus Cadila Healthcare Ltd - Pipeline by Stage of Development, 2016
Zydus Cadila Healthcare Ltd - Monotherapy Products in Pipeline, 2016
Zydus Cadila Healthcare Ltd - Combination Treatment Modalities in Pipeline, 2016
Zydus Cadila Healthcare Ltd - Partnered Products in Pipeline, 2016
Zydus Cadila Healthcare Ltd - Partnered Products/ Combination Treatment Modalities, 2016
Zydus Cadila Healthcare Ltd - Pre-Registration, 2016
Zydus Cadila Healthcare Ltd - Phase III, 2016
Zydus Cadila Healthcare Ltd - Phase II, 2016
Zydus Cadila Healthcare Ltd - Phase I, 2016
Zydus Cadila Healthcare Ltd - Preclinical, 2016
Zydus Cadila Healthcare Ltd - Discovery, 2016
Zydus Cadila Healthcare Ltd - Unknown, 2016
Zydus Cadila Healthcare Ltd - Pipeline by Target, 2016
Zydus Cadila Healthcare Ltd - Pipeline by Route of Administration, 2016
Zydus Cadila Healthcare Ltd - Pipeline by Molecule Type, 2016
Zydus Cadila Healthcare Ltd - Pipeline Products by Mechanism of Action, 2016
Zydus Cadila Healthcare Ltd - Dormant Developmental Projects,2016
Zydus Cadila Healthcare Ltd, Other Locations
Zydus Cadila Healthcare Ltd, Subsidiaries
List of Figures
Zydus Cadila Healthcare Ltd - Pipeline by Top 10 Indication, 2016
Zydus Cadila Healthcare Ltd - Pipeline by Stage of Development, 2016
Zydus Cadila Healthcare Ltd - Monotherapy Products in Pipeline, 2016
Zydus Cadila Healthcare Ltd - Combination Treatment Modalities in Pipeline, 2016
Zydus Cadila Healthcare Ltd - Partnered Products in Pipeline, 2016
Zydus Cadila Healthcare Ltd - Pipeline by Top 10 Target, 2016
Zydus Cadila Healthcare Ltd - Pipeline by Route of Administration, 2016
Zydus Cadila Healthcare Ltd - Pipeline by Molecule Type, 2016
Zydus Cadila Healthcare Ltd - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report